We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > antiviral drugs

News List

USP Offers Support for Developers of COVID-19 Antiviral Drugs and Vaccines americanpharmaceuticalreview
March 23, 2020
The U.S. Pharmacopeia (USP) is providing free technical assistance to developers of medical treatments such as antiviral drugs and vaccines that can support the public health response to the COVID-19 pandemic.
Antiviral Drug Market: HIV Drugs to Become the Key to Victory Dopine
July 04, 2018
Gilead and GSK are the most noteworthy giants on the antiviral drug market, which together accounted for 68.9% market share thereof in the world in 2017.
New uses for existing antiviral drugs biospectrumasia
April 28, 2018
A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses…